As of 28 Aug 2026, Jagsonpal Pharmaceuticals Ltd share price is ₹238.20. The stock opened at ₹238.20 and had closed at ₹242.50 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹154.90 and a high of ₹264.65. In terms of performance, Jagsonpal Pharmaceuticals Ltd share price has increased by 40.45% over the past six months and has increased by 1.73% over the last year.
JAGSNPHARM Charts
Jagsonpal Pharmaceuticals Ltd Overview
About JAGSNPHARM
Jagsonpal Pharmaceuticals engaged in the business of manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients.
Jagsonpal Pharmaceuticals Ltd Historical Performance
Jagsonpal Pharmaceuticals Ltd Fundamental Analysis
Jagsonpal Pharmaceuticals Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 85.06 | 67.37 | 75.93 | 77.50 | 78.44 |
| EBITDA | 20.07 | 14.33 | 17.17 | 19.47 | 17.03 |
| Net Profit | 13.19 | 8.76 | 10.95 | 12.57 | 10.80 |
| EPS | 2.00 | 1.25 | 1.67 | 1.88 | 1.60 |
Jagsonpal Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 62.88 |
| MACD | 3.13 |
| 20-Day SMA | 234.04 |
Jagsonpal Pharmaceuticals Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Jagsonpal Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Jagsonpal Pharmaceuticals Ltd today is ₹238.20 on NSE and ₹238.20 on BSE.
- The 52-week high of Jagsonpal Pharmaceuticals Ltd is ₹264.65, while the 52-week low is ₹154.90.
- The current market capitalisation of Jagsonpal Pharmaceuticals Ltd is approximately ₹1,571 crore.
- The P/E (Price-to-Earnings) ratio of Jagsonpal Pharmaceuticals Ltd is 34.57. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Jagsonpal Pharmaceuticals Ltd is 5.69. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Jagsonpal Pharmaceuticals Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Jagsonpal Pharmaceuticals Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Jagsonpal Pharmaceuticals Ltd has delivered a return of approximately 42.62%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Jagsonpal Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 69.05% promoters, 2.30% FIIs, 0.62% DIIs, and 19.33% public shareholders.
